What are the etiology and pathophysiology of tinea pedis (athlete's foot)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 13, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Etiology and Pathophysiology of Tinea Pedis

Tinea pedis is a superficial dermatophyte infection of the feet caused predominantly by Trichophyton rubrum, followed by T. mentagrophytes (also known as T. interdigitale) and less commonly Epidermophyton floccosum. 1, 2, 3

Causative Organisms

  • T. rubrum is the most prevalent etiologic agent globally, accounting for the majority of tinea pedis cases, with T. mentagrophytes var. interdigitale as the second most common pathogen. 1, 2, 3

  • These anthropophilic dermatophytes have undergone clonal global spread during the second half of the twentieth century, correlating with increased urbanization, use of sports facilities, and demographic shifts. 3

  • Non-dermatophyte molds (Fusarium, Aspergillus, Scopulariopsis) and yeasts can occasionally cause tinea pedis, though dermatophytes remain the primary pathogens in 84.8% of cases. 4, 5

Pathophysiologic Mechanisms

Fungal Virulence Factors

  • Dermatophytes possess expanded gene families encoding LysM domain-containing proteins that bind chitin and related carbohydrates, facilitating adherence to keratinized tissues and potentially modulating host immune recognition. 6

  • These organisms are enriched for multiple classes of proteases (keratinases) that degrade keratin, enabling fungal growth and nutrient acquisition from the stratum corneum, hair, and nails. 6

  • Dermatophyte genomes encode novel fungus-specific kinases and pseudokinases that may regulate signaling pathways involved in chronic infection establishment and immune evasion. 6

  • Secondary metabolite synthesis pathways are abundant in dermatophyte genomes, potentially producing compounds that facilitate tissue invasion or suppress local immune responses. 6

Transmission and Infection Establishment

  • Household transmission among family members is the most common route of infection, with indirect contact through contaminated footwear, floors, and bathing facilities serving as major vectors. 2, 4

  • Fungal elements can spread from the foot to other body sites via direct contact or contaminated hands, with concomitant dermatophytosis at other locations confirmed in 25% of cases. 7, 8

  • Footwear can harbor large numbers of viable dermatophyte spores, acting as a persistent reservoir for reinfection even after successful treatment. 7

Predisposing Risk Factors

Environmental and Occupational

  • Athletes demonstrate infection rates up to 22-23% compared to 8% in the general population, with a 15-fold higher prevalence of onychomycosis that can spread to cause tinea pedis. 1, 9

  • Warm, humid environments activate dormant fungal elements, with periods of increased warmth and humidity or impaired immunity triggering clinical disease. 1

  • Occlusive footwear, synthetic materials that retain sweat, water sports, and communal bathing facilities significantly increase exposure to infectious dermatophytes. 1

Host Factors

  • Male gender, adolescent and adult age (peak incidence 16-45 years), and obesity are established demographic risk factors. 1, 7, 2

  • Diabetic patients are almost three times more likely to develop tinea pedis and onychomycosis, with poor peripheral circulation, neuropathy, and impaired wound healing contributing to infection susceptibility and complications. 1

  • Genetic susceptibility exists, with familial patterns of T. rubrum infection showing autosomal dominant inheritance patterns, suggesting host immune factors influence infection establishment. 1

  • Repeated nail trauma, hyperhidrosis, and immunosuppression (HIV infection, immunosuppressive medications) compromise skin barrier function and local immune defenses. 1, 5

Clinical Progression

  • Fungal invasion of the nail can spread to the foot when activated by environmental triggers, and conversely, tinea pedis serves as a reservoir for onychomycosis development. 1

  • Concomitant onychomycosis is present in up to one-third of tinea pedis cases, requiring extended treatment and serving as a persistent source of reinfection. 1, 7

  • In diabetic patients, diseased nails with sharp edges can cause pressure erosion and skin injury that goes unnoticed due to sensory neuropathy, creating entry points for secondary bacterial infection and potentially limb-threatening complications. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Tinea pedis: an updated review.

Drugs in context, 2023

Guideline

Treatment of Tinea Pedis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Pediatric Tinea Pedis with Onychomycosis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Tinea Pedis in Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the treatment for athlete's foot?
What are the treatments for antifungal (antifungal) tinea pedis (athlete's foot)?
Can I use an antifungal cream with steroids (corticosteroids) for athlete's foot (tinea pedis)?
What is the recommended treatment for athlete's foot in a child?
What is the diagnosis and treatment for a 65-year-old male with pruritic (itchy) fissures on the soles of both feet and rashes, possibly tinea (fungal infection), on the entire body, worse on the back, chest, and abdomen?
What’s the next step for a type 2 diabetic with high hemoglobin A1c and high random plasma glucose who is on Janumet (metformin + sitagliptin) and tirzepatide (Mounjaro) 10 mg weekly?
What is the appropriate evaluation and management for a patient with persistent chest pain, negative cardiac enzymes, hypertension and uncontrolled diabetes?
How should a 7-year-old girl presenting with gross hematuria be evaluated and managed?
For a 22‑year‑old woman with normal body‑mass index who is not breastfeeding, what is the earliest safe time to initiate combined oral contraceptive therapy postpartum?
In a male adult using supraphysiologic trenbolone 150 mg weekly and testosterone 400 mg weekly who presents with new‑onset dyspnea, what is the probability that a comprehensive cardiopulmonary work‑up is warranted and what are the five most likely differential diagnoses?
In a patient being treated with antiviral medication for herpes zoster who now has an open, oozing lesion, what additional management is indicated?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.